Volasertib

未知生产厂商

Volasertib has been used in trials studying the treatment of Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, and Leukemia, Monocytic, Acute, among others.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Volasertib has been used in trials studying the treatment of Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, and Leukemia, Monocytic, Acute, among others.

技术标识符

化学式: C₃₄H₅₀N₈O₃
CAS 编号: 755038-65-4
UNII ID: 6EM57086EA

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Method for treatment of advanced solid tumors
US 9370535 B2申请人: TAUBE TILLMANN优先权: 2011
CN
US
3 件公开
METHOD FOR TREATMENT OF SOLID MALIGNANCIES INCLUDING ADVANCED OR METASTATIC SOLID MALIGNANCIES
US 2013131069 A1申请人: TAUBE TILLMANN优先权: 2011
CN
US
2 件公开
COMBINATION THERAPY WITH VOLASERTIB
US 2014154304 A1申请人: TAUBE TILLMANN优先权: 2012
CN
US
2 件公开
COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME I
US 2015031642 A1申请人: RUDOLPH DOROTHEA优先权: 2014
CN
US
2 件公开
COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME II
US 2015031643 A1申请人: RUDOLPH DOROTHEA优先权: 2014
CN
US
2 件公开
TREATMENT OF MYELODYSPLASTIC SYNDROME
US 2015031699 A1申请人: RUDOLPH DOROTHEA优先权: 2014
US
2 件公开
METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS USING VOLASERTIB
US 2023127861 A1申请人: CHILDRENS HOSPITAL MED CT优先权: 2022
US
2 件公开
Method for preparing volasertib and intermediate thereof
US 9688685 B2申请人: SUZHOU MIRACPHARMA TECH CO LTD优先权: 2014
US
Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
US 9867831 B2申请人: BOEHRINGER INGELHEIM INT优先权: 2014
US
COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA
CN 111629725 A申请人: BOEHRINGER INGELHEIM INT优先权: 2018
CN

药物